- Retatrutide — an experimental, not-FDA-approved weight-loss drug — is being widely marketed and sold online and at clinics despite federal rules that it should only be available in trials.
- CBS found 120+ websites and over 50 clinics advertising the drug; at least 21 clinics removed or changed listings after being contacted.
- Some doctors tout retatrutide as cheaper or more effective based on company trial results, prompting legal and ethical concerns about prescribing before FDA review.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.